Virus-like particles (VLPs) are nanostructures that possess diverse applications in
therapeutics, immunization, and diagnostics. With the recent advancements in biomedical …

The engineering of materials that can modulate the immune system is an emerging field that
is developing alongside immunology. For therapeutic ends such as vaccine development …

The host immune system possesses an intrinsic ability to target and kill cancer cells in a
specific and adaptable manner that can be further enhanced by cancer immunotherapy …

Current vaccines that provide protection against infectious diseases have primarily relied on
attenuated or inactivated pathogens. Virus‐like particles (VLPs), comprised of capsid …

Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-
associated antigens are excellent targets for immune therapy and vaccine design. Optimally …

The current COVID‐19 pandemic has a tremendous impact on daily life world‐wide. Despite
the ability to dampen the spread of SARS‐CoV‐2, the causative agent of the diseases …

Microbial pathogens have developed complex and efficient ways of counteracting and
evading innate and adaptive immune mechanisms. The strategies used by pathogens …

The evolution of vaccines (eg, live attenuated, recombinant) and vaccine production
methods (eg, in ovo, cell culture) are intimately tied to each other. As vaccine technology has …

Virus‐like particles (VLPs) mimic the whole construct of virus particles devoid of viral
genome as used in subunit vaccine design. VLPs can elicit efficient protective immunity as …

The past few decades have witnessed the booming field of cancer immunotherapy. Cancer
therapeutic vaccines, either alone or in combination with other immunotherapies such as …